Financials in USD. Standardized financial statements.
A compact view of how Globus Medical, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.94B | $2.52B | $1.57B | $1.02B | $958.10M | $789.04M | $785.37M | $712.97M | $635.98M | $563.99M |
| Revenue Growth? | +16.7% | +60.6% | +53.3% | +6.8% | +21.4% | +0.5% | +10.2% | +12.1% | +12.8% | 0.0% |
| Cost of Revenue? | $957.80M | $1.04B | $548.17M | $263.73M | $239.22M | $217.46M | $179.97M | $159.41M | $150.45M | $134.71M |
| Gross Profit? | $1.98B | $1.48B | $1.02B | $759.12M | $718.88M | $571.58M | $605.39M | $553.56M | $485.52M | $429.29M |
| Gross Margin? | +67.4% | +58.9% | +65.1% | +74.2% | +75.0% | +72.4% | +77.1% | +77.6% | +76.3% | +76.1% |
| Operating Expenses? | $1.50B | $1.32B | $887.16M | $531.17M | $546.93M | $460.15M | $433.40M | $384.23M | $323.68M | $275.15M |
| Operating Income? | $479.80M | $165.99M | $133.14M | $227.95M | $171.95M | $111.43M | $171.99M | $169.32M | $161.84M | $154.14M |
| EBITDA? | $729.90M | $473.73M | $346.58M | $304.50M | $264.73M | $178.35M | $229.49M | $218.51M | $205.39M | $192.99M |
| Income Before Tax | $609.90M | $120.72M | $165.39M | $243.02M | $180.41M | $125.90M | $189.95M | $188.60M | $169.93M | $157.28M |
| Income Tax Expense | $72.00M | $17.74M | $42.52M | $52.85M | $31.22M | $23.61M | $34.74M | $32.13M | $62.58M | $52.94M |
| Net Income? | $537.90M | $102.98M | $122.87M | $190.17M | $149.19M | $102.28M | $155.21M | $156.47M | $107.35M | $104.34M |
| EPS? | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 |
| Diluted EPS? | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality